A malaria drug which Donald Trump was condemned for hailing as a possible COVID-19 treatment can increase survival rates by up to 200 per cent, scientists say.
Scientists found that, when ventilated patients with a severe version of COVID were given high doses of hydroxychloroquine with zinc, their survival rates could increase dramatically.
Trump said in March 2020 he was taking it to prevent him catching the virus, rather than treat it. He did not become infected until October, and was not treated with the drug.
The former president had previously touted hydroxy as a potential miracle treatment, with scientists lining up to insist he was wrong to do so.
Yet Trump’s allies on Wednesday were highlighting the study, conducted by Saint Barnabas Medical Center in New Jersey on 255 patients.
It was published on May 31 on the medical site medRxiv.
Trump’s spokesman, Jason Miller, tweeted: ‘Oh.’
He quoted: ‘Study shows hydroxychloroquine and zinc treatments increased coronavirus survival rate by almost three times’
His son, Donald Trump Jr, said: ‘In the last week alone, we’ve learned that the media, so-called fact checkers and their Big Tech enforcers lied to us about the lab-leak theory, Hydroxychloroquine and the clearing of Lafayette Square.
‘All to hurt Donald Trump.
‘What else are they lying about?’